Intermittent claudication as a manifestation of silent myocardial ischemia: a pilot study

A M Salmasi1, A Nicolaides, A Al-Katoubi

  • 1Vascular Section, Irvine Laboratory for Cardiovascular Investigation and Research, St. Mary's Hospital Medical School, London, United Kingdom.

Insights

Silent myocardial ischemia is common in patients with intermittent claudication, causing cardiac dysfunction and early exercise limitation. Treatments like myocardial revascularization improve cardiac function and walking ability.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Exercise Physiology

Background:

  • Intermittent claudication (IC) is a common symptom of peripheral artery disease.
  • Silent myocardial ischemia (SMI) may coexist and impact exercise capacity.
  • Noninvasive screening for SMI in IC patients is valuable.

Purpose of the Study:

  • To investigate the prevalence and impact of SMI in patients with IC.
  • To assess the effect of interventions on cardiac function and exercise tolerance.

Main Methods:

  • 100 IC patients underwent electrocardiography chest wall mapping stress tests and transcutaneous aortovelography.
  • Coronary angiography confirmed findings in 32 patients with identified coronary artery disease.
  • Evaluated changes after myocardial revascularization or medical therapy.

Main Results:

  • SMI was detected in 32% of patients, correlating with reduced stroke distance (cardiac stroke volume).
  • Interventions led to significant improvements in post-exercise stroke distance and recovery time.
  • Claudication distance improved significantly in treated patients.

Conclusions:

  • SMI is prevalent in IC patients, contributing to left ventricular dysfunction and early claudication.
  • Myocardial revascularization and medical therapy can improve cardiac function and exercise capacity.
  • Noninvasive screening for SMI is crucial in managing IC patients.